The global healthcare industry is undergoing a major transformation as biologics continue to redefine modern medicine. From monoclonal antibodies and vaccines to cell therapies and recombinant proteins, biologics manufacturing has become one of the most critical pillars of pharmaceutical innovation. Growing investments in biotechnology, rising chronic disease prevalence, and expanding demand...

The global healthcare industry is undergoing a major transformation as biologics continue to redefine modern medicine. From monoclonal antibodies and vaccines to cell therapies and recombinant proteins, biologics manufacturing has become one of the most critical pillars of pharmaceutical innovation. Growing investments in biotechnology, rising chronic disease prevalence, and expanding demand...

The global healthcare industry is undergoing a major transformation as biologics continue to redefine modern medicine. From monoclonal antibodies and vaccines to cell therapies and recombinant proteins, biologics manufacturing has become one of the most critical pillars of pharmaceutical innovation. Growing investments in biotechnology, rising chronic disease prevalence, and expanding demand...